SYSTEM PROBLEMS:
We are currently experiencing technical problems with content and functionality requiring a login.
We apologize for the inconvience.
Showing session: reset
Making Sense of Integrase Strand Transfer Inhibitor Failure and Resistance
- Sort by:
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
4 of
4
|
Dolutegravir Resistance: How Frequent Is It and How Will It Evolve? (ABSTRACT
46)
Nicaise Ndembi
Africa Centres for Disease Control and Prevention, Addis Ababa, Ethiopia
Dolutegravir Resistance: What Are the Implications for Antiretroviral Therapy Programs? (ABSTRACT
47)
Jeremy Nel
University of Witwatersrand, Johannesburg, South Africa
Long-Acting InSTI Strategies: Understanding the Risks for Failure and Resistance (ABSTRACT
48)
Saye Khoo
University of Liverpool, Liverpool, UK
Panel Discussion
Brenda E. Crabtree RamÃrez
National Institute of Medical Science and Nutrition Salvador Zubiran, Mexico City, Mexico
Suzanne McCluskey
Massachusetts General Hospital, Boston, MA, USA
Anna Turkova
MRC Clinical Trials Unit at UCL, London, UK
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
4 of
4
|
